Literature DB >> 336208

Cell cycle characteristics of synchronized and asynchronous populations of human cells and effect of cooling of selected mitotic cells.

E O Pettersen, O Bakke, T Lindmo, R Oftebro.   

Abstract

The method of synchronizing cells by means of mitotic selection has been adapted to the human line NHIK 3025. Increase in cell number as a function of time in asynchronous and synchronous populations was studied as well as mitotic index as a function of time after selection of synchronized populations. Phase durations of the cell cycle of synchronous populations were determined by 3H-thymidine incorporation and scintillation counting. The relative phase durations of exponentially growing asynchronous populations were determined by mathematical analysis of DNA-histograms recorded by flow cytofluorimetry. Both the generation time and the various phase durations of the cell cycle were found to be the same in asynchronous and synchronous populations. It was found that NHIK 3025 cells are damaged by cooling to 4 and 0 degrees C so that cooling of selected cells in order to increase the yield would reduce the quality of the synchronized populations.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 336208     DOI: 10.1111/j.1365-2184.1977.tb00309.x

Source DB:  PubMed          Journal:  Cell Tissue Kinet        ISSN: 0008-8730


  19 in total

1.  Porphyrin-sensitized photoinactivation of human cells in vitro.

Authors:  J Moan; J V Johannessen; T Christensen; T Espevik; J B McGhie
Journal:  Am J Pathol       Date:  1982-11       Impact factor: 4.307

2.  Effect of two pyrimidine analogs on accumulation of tubulin in NHIK 3025 cells.

Authors:  M E Juul; J M Dornish; N O Juul; E O Pettersen; R Oftebro
Journal:  Mol Cell Biochem       Date:  1990-08-10       Impact factor: 3.396

3.  Multipolar mitotic cells in the human cell line NHIK 3025 following treatment with the mitotic inhibitor NY 4137.

Authors:  M E Juul; J M Dornish; P E Schwarze; E O Pettersen; R Oftebro
Journal:  Invest New Drugs       Date:  1991-02       Impact factor: 3.850

4.  Mitotic arrest and interphase inhibition induced by the pyrimidine sulfoxide NY 4138.

Authors:  E O Pettersen; O Nome; J M Dornish; R Oftebro
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

5.  Effects of the new mitotic inhibitor pyrimidinsulfone NY 4137 on human cells in vitro and on colchicine binding to tubulin.

Authors:  M E Nygaard; J M Dornish; R Oftebro; K Undheim
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

6.  Inactivation of human cells cultivated in vitro by the new mitotic inhibitors NY 4137 and NY 4138.

Authors:  M E Nygaard; E O Pettersen; J M Dornish; K Undheim; R Oftebro
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850

7.  Cell-cycle inhibition by misonidazole of human cells cultivated in vitro under aerobic conditions.

Authors:  T Lindmo; E O Pettersen; E Wibe
Journal:  Br J Cancer       Date:  1979-11       Impact factor: 7.640

8.  Photodynamic effect of haematoporphyrin throughout the cell cycle of the human cell line NHIK 3025 cultivated in vitro.

Authors:  T Christensen; J Moan; E Wibe; R Oftebro
Journal:  Br J Cancer       Date:  1979-01       Impact factor: 7.640

9.  The binding of cis-dichlorodiammineplatinum(II) to extracellular and intracellular compounds in relation to drug uptake and cytotoxicity in vitro.

Authors:  J E Melvik; J M Dornish; E O Pettersen
Journal:  Br J Cancer       Date:  1992-08       Impact factor: 7.640

10.  Regulation of cell proliferation under extreme and moderate hypoxia: the role of pyrimidine (deoxy)nucleotides.

Authors:  O Amellem; M Löffler; E O Pettersen
Journal:  Br J Cancer       Date:  1994-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.